Sun 15 Nov 2026 15:52:07 BST
Search Company
*

Active Substance
New Active Substance
Search Site
--
*

Create Site
--
*
*
*
*
*
*
Update Site
Current data stored in EudraGMDP databaseCurrent data stored in OMS
--
Characters remaining:4000/4000
New Active Substance Importation
Active Substance*
Active Substance (English):
Active Substance (NL):
NCA Reference Key:
3rd Country Manufacturer
3rd Country ManufacturerOMS Location IdentifierOMS Organisation IdentifierLegal AddressNCA Reference KeyConfidentialEditDelete
No records found.

3rd Country Distributor
3rd Country DistributorOMS Location IdentifierOMS Organisation IdentifierLegal AddressNCA Reference KeyConfidentialEditDelete
No records found.

RTF Template


National Agency For The Safety Of Medicine And Health Products

UNION FORMAT FOR A WHOLESALE DISTRIBUTION AUTHORISATION


1. Authorisation Number

:

2021_219_4_5_15

2. Name of Authorisation Holder

:

RBP PHARMA SAS

3. Address(es) of Site(s)

:

ZA de Pré-Million 2, Bâtiment Bel Horizon, LA TERRASSE, 38660, France 




4. Legally registered address of Authorisation Holder

:

ZA de Pré-Million 2, Bâtiment Bel Horizon, LA TERRASSE, 38660, France

5. Scope of authorisation (complete for each site under 4)

:

ANNEX 1

6. Legal basis of authorisation

:


7. Name of responsible officer of the competent authority of the member state granting the wholesaling authorisation

:

Confidential, Confidential

8. Signature

:


9. Date

:

2021-12-29

10. Annexes attached

:

Annex 1 Scope of wholesale distribution authorisation

Annex 2 (Optional) Address(es) of contract wholesale distribution sites and their authorisation number

Annex 3 (Optional) Name(s) of responsible person(s)

Annex 4 (Optional) Date of Inspection on which authorisation was granted

Annex 5 (Optional) Additional provisions based on national requirements


ANNEX 1

SCOPE OF WHOLESALE DISTRIBUTION AUTHORISATION



Name and address of the site: RBP PHARMA SAS

, ZA de Pré-Million 2, Bâtiment Bel Horizon, LA TERRASSE, 38660, France   




1. MEDICINAL PRODUCTS

   1.1. with a Marketing Authorisation in EEA country(s)

   1.2. without a Marketing Authorisation in the EEA and intended for EEA market


2. AUTHORISED WHOLESALE DISTRIBUTION OPERATIONS

   2.1. Procurement 

   2.2. Holding 

   2.3. Supply 

   2.4. Export 


3. MEDICINAL PRODUCTS WITH ADDITIONAL REQUIREMENTS

     3.1.1. Narcotic or psychotropic products 

     3.1.2. Medicinal products derived from blood 

     3.1.3. Immunological medicinal products 

   3.3. Cold chain products(requiring low temperature handling) 




Any restrictions or clarifying remarks (for all users):  Dépositaire, wholesale distributor and central purchasing office (Public Health Code Article R.5124-2 4°, 5° and 15°)

4° storage, wholesale distribution of not owned medicinal products, by order and on behalf of exploitants
-
5° purchase, storage, distribution of medicinal products (except investigational); can distribute by order and on behalf of licensed pharmacists of pharmacy  or structures mentioned in Article D. 5125-24-16, on the national territory only, medicinal products (except investigational ones) and non refundable
-
15° purchase, storage, distribution to licensed pharmacists of pharmacy, on the national territory only, of non refundable medicinal products (except investigational ones)"

Signatory: Mr Said Ioughlissen, deputy head of pharmaceutical product inspection and counterfeiting fight department --- The ANSM does not issue hard copy of this authorisation.
---

Etablissement dépositaire, grossiste-répartiteur et centrale d'achat pharmaceutique (code de la santé publique art. R.5124-2 4°, 5° and 15°)

4° stockage, distribution en gros et en l'état de médicaments dont il n'est pas propriétaire, d'ordre et pour le compte d'exploitants
-
5° achat, stockage, distribution de médicaments non expérimentaux;  peut aussi distribuer d'ordre et pour le compte de titulaires d'officine ou de structures citées à l'art. D.5125-24-1, sur le territoire national uniquement, des médicaments non remboursables (hors médicaments expérimentaux)
-
15° achat, stockage, distribution à des pharmaciens titulaires d'officine, sur le territoire national uniquement, de médicaments non remboursables (hors médicaments expérimentaux)

Signataire : M. Said Ioughlissen, chef adjoint du Pôle inspection des produits pharmaceutiques et lutte contre les fraudes --- L'ANSM ne délivre pas de copie papier de cette autorisation.



*Art 5 of Directive 2001/83/EC or Art 83 of Regulation EC/726/2004

**Without prejudice to further authorisations as may be required according to national legislation













Union Format for a Wholesale Distribution Authorisation

2021_219_4_5_15


Page 1





Loading, please wait